MIP-1β but not IFN-γ are associated with nonprogressive HIV-1 infection

Sarah Kutscher(Helmholtz Munich), Antonio Cosma(Luxembourg Institute of Health), Guido Poli(University of Verona), Simone Allgayer(Helmholtz Munich), Johannes R. Bogner(Klinik und Poliklinik für Orthopädie, Physikalische Medizin und Rehabilitation), Volker Erfle, Priscilla Biswas(Mario Negri Institute for Pharmacological Research), Dieter Hoffmann(Technical University of Munich), Mauro Malnati(Vita-Salute San Raffaele University), Paolo Lusso(National Institute of Allergy and Infectious Diseases), Silvia Heltai(IRCCS Ospedale San Raffaele), Giuseppe Tambussi(San Raffaele University of Rome), Peter Reitmeir(Institute of Groundwater Ecology), Ulrike Protzer(German Center for Infection Research), Hans-J rgen Stellbrink, Silvia Ghezzi(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), F. D. Goebel(LMU Klinikum), Marco Tinelli(Ospedale Maggiore di Lodi)
Unknown
January 1, 2010
Cited by 0

Related Papers

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
|The Lancet Oncology|2016|1k
Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
|Science|2014|876
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV
|Nature|2021|734
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
|Nature Medicine|1997|635